B. Jan

Construction of a minimal HIV-1 variant that selectively replicates in leukemic derived T-cell lines: towards a new virotherapy approach.

B. Berkhout, R. Jeeninga, H. van den Berg, 2005, Cancer research.

Construction of doxycyline-dependent mini-HIV-1 variants for the development of a virotherapy against leukemias

B. Berkhout, R. Jeeninga, H. van den Berg, 2006, Retrovirology.